๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 10,165 authorised medicines
MedicineActive substanceLicence holderStatus
ALTUVOCT 2 000 IU Powder and solvent for solution for injection
EU/1/24/1824/005
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ALTUVOCT 250 IU Powder and solvent for solution for injection
EU/1/24/1824/001
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ALTUVOCT 3 000 IU Powder and solvent for solution for injection
EU/1/24/1824/006
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ALTUVOCT 4 000 IU Powder and solvent for solution for injection
EU/1/24/1824/007
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ALTUVOCT 500 IU Powder and solvent for solution for injection
EU/1/24/1824/002
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ALTUVOCT 750 IU Powder and solvent for solution for injection
EU/1/24/1824/003
Efanesoctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
Alunbrig 180 mg film-coated tablets
EU/1/18/1264/009-010
Brigatinib Takeda Pharma A/S โ€”
Alunbrig 30 mg film-coated tablets
EU/1/18/1264/001-004
Brigatinib Takeda Pharma A/S โ€”
Alunbrig 90 mg film-coated tablets
EU/1/18/1264/005-008
Brigatinib Takeda Pharma A/S โ€”
ALUTARD SQ Bee 100 000 SQ-U/ml suspension for injection
PA1255/008/001
Apis mellifera ALK-Abello A/S Marketed
ALUTARD SQ Bee Initial Pack (100 SQ-U/ml, 1 000 SQ-U/ml, 10 000 SQ-U/ml and 100 000 SQ-U/ml) suspension for injection
PA1255/008/002
Apis mellifera, Apis mellifera, Apis mellifera, Apis mellifera ALK-Abello A/S Marketed
ALUTARD SQ Wasp 100 000 SQ-U/ml suspension for injection
PA1255/009/001
Vespula spp. ALK-Abello A/S Marketed
ALUTARD SQ Wasp Initial Pack (100 SQ-U/ml, 1 000 SQ-U/ml, 10 000 SQ-U/ml and 100 000 SQ-U/ml) suspension for injection
PA1255/009/002
Vespula spp., Vespula spp., Vespula spp., Vespula spp. ALK-Abello A/S Marketed
Alvesco 160 microgram pressurised inhalation, solution
PPA0465/515/001
Ciclesonide PCO Manufacturing Ltd. โ€”
Alvesco 160 micrograms pressurised inhalation, solution
PA22986/001/002
Ciclesonide Covis Pharma Europe B.V. Marketed
Alvesco 160 micrograms pressurised inhalation, solution
PPA1463/175/001
Ciclesonide IMED Healthcare Ltd., โ€”
Alvesco 80 micrograms pressurised inhalation, solution
PA22986/001/001
Ciclesonide Covis Pharma Europe B.V. Marketed
Alyftrek 125 mg/50 mg/10 mg film-coated tablets
EU/1/25/1943/002
Vanzacaftor, TEZACAFTOR, Deutivacaftor Vertex Pharmaceuticals (Ireland) Limited โ€”
Alyftrek 50 mg/20 mg/4 mg film-coated tablets
EU/1/25/1943/001
Vanzacaftor, TEZACAFTOR, Deutivacaftor Vertex Pharmaceuticals (Ireland) Limited โ€”
Alymsys 25 mg/mL concentrate for solution for infusion
EU/1/20/1509/001-002
Bevacizumab Mabxience Research, S.L. โ€”
Amantadine hydrochloride Renata 100 mg Capsules, hard
PA22865/005/001
AMANTADINE HYDROCHLORIDE Renata Pharmaceuticals (Ireland) Limited Marketed
Ambirix suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
EU/1/02/224/005
Hepatitis b surface antigen (hbs ag), Hepatitis a virus GlaxoSmithKline Biologicals S.A. โ€”
Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
EU/1/02/224/001
Hepatitis b surface antigen (hbs ag), Hepatitis a virus GlaxoSmithKline Biologicals S.A. โ€”
Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
EU/1/02/224/002
Hepatitis b surface antigen (hbs ag), Hepatitis a virus GlaxoSmithKline Biologicals S.A. โ€”
Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
EU/1/02/224/003
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) GlaxoSmithKline Biologicals S.A. โ€”
Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
EU/1/02/224/004
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) GlaxoSmithKline Biologicals S.A. โ€”
AmBisome Liposomal Amphotericin B 50 mg Powder for Concentrate for Dispersion for Infusion
PA2322/001/001
Amphotericin b Gilead Sciences Ireland UC Marketed
Ambrisentan Accord 10 mg film-coated tablets
PA2315/235/002
Ambrisentan Accord Healthcare Ireland Ltd. Marketed
Ambrisentan Accord 5 mg film-coated tablets
PA2315/235/001
Ambrisentan Accord Healthcare Ireland Ltd. Marketed
Ambrisentan Viatris 10 mg film-coated tablets
EU/1/19/1368/003-004
Ambrisentan Viatris Limited โ€”
Ambrisentan Viatris 5 mg film-coated tablets
EU/1/19/1368/001-002
Ambrisentan Viatris Limited โ€”
Ameluz 78 mg/g gel
EU/1/11/740/001
5-aminolevulinic acid hydrochloride Biofrontera Bioscience GmbH โ€”
Ametop 40 mg/g Gel
PA2325/002/001
Tetracaine base Alliance Pharma (Ireland) Limited Marketed
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/001
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/010
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled pen
EU/1/16/1164/014- 016
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/002-009
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/011-013
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 80 mg solution for injection in pre-filled pen
EU/1/16/1164/020- 022
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 80 mg solution for injection in pre-filled syringe
EU/1/16/1164/017-019
Adalimumab Amgen Europe B.V., โ€”
AMGLIDIA 0.6 mg/mL oral suspension
EU/1/18/1279/001-002
Glibenclamide AMMTek โ€”
AMGLIDIA 6 mg/mL oral suspension
EU/1/18/1279/003-004
Glibenclamide AMMTek โ€”
AMIDAFLUID 1 mg/ml, eye drops, solution
PA23520/001/001
Propamidine isetionate Horus Pharma Not marketed
Amidex 1 mg film-coated tablets
PA0126/189/001
Anastrozole Clonmel Healthcare Ltd Marketed
Amifampridine SERB 10 mg tablets
EU/1/22/1646/001-003
Amifampridine Phosphate SERB S.A. โ€”
Amikacin 125 mg/ml Solution for injection/infusion
PA1122/034/001
AMIKACIN SULFATE Noridem Enterprises Limited Not marketed
Amikacin 250 mg/ ml Solution for injection/infusion
PA1418/012/001
AMIKACIN SULFATE Athlone Pharmaceuticals Limited Not marketed
Amikacin 250 mg/ml Solution for injection/infusion
PA1122/034/002
AMIKACIN SULFATE Noridem Enterprises Limited Not marketed
Amikacin 5 mg/ml solution for infusion
PA2059/072/001
Amikacin Fresenius Kabi Deutschland GmbH Marketed
Amikacin Caragen 250 mg/ml solution for injection/infusion
PA22939/001/001
Amikacin Caragen Limited Marketed
โ† 4 5 6 7 8 9 10 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.